Treatment of unstable pulmonary embolism in the elderly and those with comorbid conditions

American Journal of Medicine

Volumn 126, Issue 4, 2013, Pages 304-310

  Stein, Paul D ^a,b   Matta, Fadi ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b ST MARY MERCY HOSPITAL   (United States)

Author keywords

Pulmonary embolism; Thrombolytic therapy; Venous thromboembolism

Indexed keywords

FIBRINOLYTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEMENTIA; FATALITY; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART INFARCTION; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LEUKEMIA; LIVER DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; DRUG UTILIZATION; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY EMBOLISM; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 84875228527     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.12.007     Document Type: Article

References (25)

1. P.D. Stein, F. Matta Thrombolytic therapy in unstable patients with acute pulmonary embolism: save lives but underused Am J Med 125 2012 465 470
2. N. Kucher, E. Rossi, M. De Rosa, S.Z. Goldhaber Massive pulmonary embolism Circulation 113 2006 577 582
3. HCUP Nationwide Inpatient Sample (NIS) Healthcare Cost and Utilization Project (HCUP) 1998-2008 Agency for Healthcare Research and Quality Rockville, MD www.hcup-us.ahrq.gov/nisoverview.jsp Accessed January 23, 2012
4. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
5. K.M. Mikkola, S.R. Patel, J.A. Parker, F. Grodstein, S.Z. Goldhaber Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis Am Heart J 134 1997 69 72
6. P.D. Stein, F. Matta, D.S. Steinberger, D.C. Keyes Intracerebral hemorrhage with thombolytic therapy for acute pulmonary embolism Am J Med 125 2012 50 56
7. S. Konstantinides, A. Geibel, G. Heusel, F. Heinrich, W. Kasper Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism N Engl J Med 347 2002 1143 1150
8. S.Z. Goldhaber, W.D. Haire, M.L. Feldstein Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion Lancet 341 1993 507 511
9. M. Levine, J. Hirsh, J. Weitz A randomized trial of a single bolus dosage regimen a recombinant tissue plasminogen activator in patients with acute pulmonary embolism Chest 98 1990 1473 1479
10. S.Z. Goldlhaber, C.M. Kessler, J.A. Heit Recombinant tissue-type plasminogen activator versus a novel-dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial J Am Coll Cardiol 20 1992 24 30
11. G. Meyer, H. Sors, B. Charbonnier Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial J Am Coll Cardiol 19 1992 239 245
12. B.F. Gage, Y. Yan, P.E. Milligan Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF) Am Heart J 151 2006 713 719
13. P.M. Kuijer, B.A. Hutten, M.H. Prins, H.R. Büller Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism Arch Intern Med 159 1999 457 460
14. R. Pisters, D.A. Lane, R. Nieuwlaat A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
15. K. Fiumara, N. Kucher, J. Fanikos, S.Z. Goldhaber Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism Am J Cardiol 97 2006 127 129
16. S. Konstantinides, A. Geibel, M. Olschewski Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry Circulation 96 1997 882 888
17. S.A. Ibrahim, R.A. Stone, D.S. Obrosky Thrombolytic therapy and mortality in patients with acute pulmonary embolism Arch Intern Med 168 2008 2183 2190
18. J.E. Dalen, J.S. Alpert, J. Hirsh Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med 157 1997 2550 2556
19. P.S. Romano, D.H. Mark Bias in the coding of hospital discharge data and its implications for quality assessment Med Care 32 1994 81 90
20. E.S. Fisher, F.S. Whaley, W.M. Krushat The accuracy of Medicare's hospital claims data: progress has been made, but problems remain Am J Public Health 82 1992 243 248
21. W.D. Kniffin Jr, J.A. Baron, J. Barrett The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly Arch Intern Med 154 1994 861 866
22. P.D. Stein, F. Kayali, R.E. Olson, C.E. Milford Pulmonary thromboembolism in Asian/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census Am J Med 116 2004 435 442
23. M.C. Proctor, L.J. Greenfield Pulmonary embolism: diagnosis, incidence, and implications Cardiovasc Surg 5 1997 77 81
24. P.D. Stein, J.W. Henry Prevalence of acute pulmonary embolism in a general hospital and at autopsy Chest 108 1995 978 981
25. P.D. Stein, K.C. Patel, N.J. Kalra Estimated incidence of acute pulmonary embolism in a community/teaching general hospital Chest 121 2002 802 805